CN105603120B - GeXP multiple rapid detection primer and detection method for detecting bluetongue virus, bovine viral diarrhea virus and foot-and-mouth disease virus - Google Patents
GeXP multiple rapid detection primer and detection method for detecting bluetongue virus, bovine viral diarrhea virus and foot-and-mouth disease virus Download PDFInfo
- Publication number
- CN105603120B CN105603120B CN201510784508.XA CN201510784508A CN105603120B CN 105603120 B CN105603120 B CN 105603120B CN 201510784508 A CN201510784508 A CN 201510784508A CN 105603120 B CN105603120 B CN 105603120B
- Authority
- CN
- China
- Prior art keywords
- virus
- detection
- foot
- primer
- bovine viral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000710198 Foot-and-mouth disease virus Species 0.000 title claims abstract description 15
- 238000001514 detection method Methods 0.000 title abstract description 33
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 title abstract description 7
- 241000120506 Bluetongue virus Species 0.000 title abstract description 3
- 241000283690 Bos taurus Species 0.000 claims abstract description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 20
- 208000003836 bluetongue Diseases 0.000 claims description 9
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 claims description 8
- 206010051511 Viral diarrhoea Diseases 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 19
- 235000013365 dairy product Nutrition 0.000 abstract description 16
- 230000035945 sensitivity Effects 0.000 abstract description 10
- 108090000623 proteins and genes Proteins 0.000 abstract description 9
- 238000000034 method Methods 0.000 abstract description 8
- 239000013612 plasmid Substances 0.000 abstract description 6
- 244000052769 pathogen Species 0.000 abstract description 3
- 230000014509 gene expression Effects 0.000 abstract description 2
- 239000013558 reference substance Substances 0.000 abstract 2
- 238000012252 genetic analysis Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 241000700605 Viruses Species 0.000 description 21
- 241001465754 Metazoa Species 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 238000003757 reverse transcription PCR Methods 0.000 description 9
- 230000003321 amplification Effects 0.000 description 8
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 238000012360 testing method Methods 0.000 description 6
- 238000005251 capillar electrophoresis Methods 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- PPBOKXIGFIBOGK-BDTUAEFFSA-N bvdv Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C1=CN=CN1 PPBOKXIGFIBOGK-BDTUAEFFSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 108020000999 Viral RNA Proteins 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 208000003322 Coinfection Diseases 0.000 description 2
- 238000010802 RNA extraction kit Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000003748 differential diagnosis Methods 0.000 description 2
- 238000007403 mPCR Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 230000010530 Virus Neutralization Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 238000011841 epidemiological investigation Methods 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 238000010206 sensitivity analysis Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to a primer and a detection method for GeXP multiple rapid detection for detecting bluetongue virus, bovine viral diarrhea virus and foot and mouth disease virus, which are used for establishing a plurality of dairy cow epidemic disease detection methods based on a GeXP multiple gene expression genetic analysis system, solving the problems that the serology method has low sensitivity when a plurality of dairy cow epidemic diseases are detected, the conventional PCR can only detect single pathogen, the cost of a gene chip method is high and the like, and constructing 3 dairy cow epidemic disease DNA positive sample standard plasmids; taking a reference substance which is 10 times of the plasmid DNA and is continuously diluted as a detection object, and detecting the reference substance with the sensitivity of 10-100 copies; no cross reaction and false negative with other dairy cow epidemic diseases; 600 parts of actual samples are detected, and the monitoring and screening requirements of a large number of dairy cows on various epidemic diseases are met.
Description
Technical Field
The invention relates to the field of biotechnology application, in particular to a method for simultaneously detecting and identifying virus diseases of three entry cows.
Background
Foot and Mouth Disease (FMD), Bovine Viral Diarrhea (BVD) and Bluetongue (BT) are 3 Viral diseases that require quarantine of entry cows prescribed by the country. In recent years, with the increase of national demand for high-quality dairy products, the number of the dairy cows entering the dairy cows rises year by year, and certain working pressure and expenditure burden are brought to the laboratory for detecting the epidemic diseases of the animals at the entry port of the dairy cows. Therefore, the establishment of the high-flux rapid detection method capable of simultaneously identifying and diagnosing the epidemic diseases of the multiple dairy cows has important significance for reducing the workload of the detection laboratory of the entry ports of the dairy cows, reducing the detection expenditure and developing the epidemiological investigation of the epidemic diseases carried by the entry dairy cows.
At present, for various viral diseases of entry cows, virus separation, serology and molecular biology methods are generally applied to detection in port animal quarantine laboratories. Virus isolation culture is a diagnostic gold standard, but has the problems of long test period, complex operation and the like; the virus neutralization test needs specific standard serum or virus strains, and has certain limitation in practical application; imported enzyme linked immunosorbent assay kits are generally expensive; common molecular biological methods such as PCR, fluorescent quantitative PCR and the like are all used for single virus detection, and can not meet the detection requirements of differential diagnosis of mixed infection of various pathogens. The multiplex PCR technology has been applied to differential diagnosis of various pathogens, but cannot realize high-throughput detection in a true sense due to amplification preference.
Disclosure of Invention
In recent years, due to the annual increase of the number of imported dairy cows, animal quarantine workers who undertake the detection task of epidemic diseases of the imported dairy cows urgently need a detection method with high sensitivity and good specificity to meet the working requirements of reducing the incoming risk of the epidemic diseases of foreign animals and realizing quick customs clearance. At present, most of the port animal testing laboratories use serological (enzyme linked immunosorbent assay) experiments, each detection kit can only test a single animal epidemic disease, cannot identify mixed infection of a plurality of animal epidemic diseases, and the expensive price of imported detection kits brings great economic pressure to the detection laboratories. Therefore, establishing a high-throughput, rapid and good-specificity detection method has important significance for reducing the risk of spreading the animal epidemic disease, accelerating entry animal clearance, promoting trade convenience and reducing the detection cost of the animal epidemic disease.
The GeXP multiple gene expression analysis system combines a multiple PCR technology and a capillary electrophoresis technology, and has the advantages of high-throughput detection of multiple PCR amplification and the characteristic of high sensitivity of capillary electrophoresis. GeXP is technically characterized in that a universal primer sequence is added to the 5' end of a specific primer to form a specific chimeric primer. In the PCR reaction process, the specific chimeric primers are firstly combined with corresponding templates respectively to ensure the specificity of subsequent amplification, and after a plurality of cycles, the universal primers dominate the subsequent amplification, so that the interference between different primers in the same reaction system can be reduced, the amplification efficiency of each pair of primers tends to be consistent, and the problem of amplification preference of the conventional multiplex PCR technology is effectively solved.
According to the research, multiple pairs of specific primers and universal primers are respectively designed according to gene conserved sequences of 3 epidemic viruses of the imported dairy cows, reaction conditions are optimized, the specificity and the accuracy of amplification of each pair of primers in a GeXP multiplex RT-PCR system are verified by detecting a single virus template and a mixed virus template, a GeXP high-throughput method for simultaneously detecting 3 dairy cows is established, the detection sensitivity can reach at least 102Copies/. mu.L. The method can be used for molecular diagnosis of viral diseases of entry cow and epidemiology of epidemic diseases of overseas cowSurveys provide technical support. In the future, a large number of positive samples or virus strains are needed to further verify and optimize the method.
Drawings
FIG. 1-FIG. 4 GeXP multiplex RT-PCR specificity verification results (FIG. 1, BTV; FIG. 2, BVDV; FIG. 3, FMDV; FIG. 4, 50bp-800bp Marker), wherein the Y-axis is relative fluorescence unit and shows the fluorescence intensity of the amplification product, and the X-axis is the size of the amplification product during capillary electrophoresis.
FIG. 5-FIG. 10 GeXP multiplex RT-PCR results for sensitivity to 3 viral templates (FIGS. 5, 10)6copies/. mu.L; FIGS. 6 and 105copies/. mu.L; FIGS. 7 and 104copies/. mu.L; FIGS. 8 and 103copies/. mu.L; FIGS. 9 and 102copies/. mu.L; FIG. 10, 50bp-800bp Marker).
Detailed Description
The GeXP start Kit, the DNA size standard Kit, the separation buffer and the loading buffer are purchased from Beckmann corporation, the one-step RT-PCR Kit, the RNA extraction Kit and the gene purification Kit are purchased from QIAGEN, Germany, the T7 in vitro transcription Kit, the Spe I restriction endonuclease and the RNA enzyme inhibitor are purchased from Dalibao biology, and the pGEX-T vector is purchased from Promega.
References select conserved regions of each viral gene and download gene sequences of 3 viruses from GenBank databases, analyze sequence homology by DNASTAR software, and design multiple specific primers using GeXP extpress Profiler tool. The 5' ends of the forward and reverse specific primers are respectively connected with a non-homologous sequence as a universal primer (Tag) to form a specific chimeric primer. Primers were synthesized by Invitrogen and purified by HPLC.
SEQ ID NO: 1-BT 3: 5'-AGGTGACACTATAGAATAGTTCTCTAGTTGACCACC-3' 5, the 5 ' end is labelled with cy 5;
SEQ ID NO：2-BT4：5′-GTACGACTCACTATAGGGAAAGCCAGACTGTTTCCCGAT-3′；
SEQ ID NO: 3-BVDV 3: 5'-AGGTGACACTATAGAATAAGCGAAGGCCGAAAAGAGGCTA-3' 5, the 5 ' end is labelled with cy 5;
SEQ ID NO：4-BVDV4：
5′-GTACGACTCACTATAGGGAAACTCCATGTGCCATGTACAGCAG-3′；
SEQ ID NO: 5-FMDV 3: 5'-AGGTGACACTATAGAATAGCCTGGTCTTTCCAGGTCT-3' 5, the 5 ' end is labelled with cy 5;
SEQ ID NO：6-FMDV4：5′-GTACGACTCACTATAGGGACCAGTCCCCTTCTCAGATC-3′；
SEQ ID NO: 7-Universal primer 1: 5'-AGGTGACACTATAGAATA-3' 5, the 5 ' end is labelled with cy 5;
SEQ ID NO: 8-Universal primer 2: 5'-GTACGACTCACTATAGGGA-3', respectively;
inactivated BT, BVDV and FMDV strains are stored in the laboratory. Viral RNA was extracted using QIAGEN RNA extraction kit (elution volume: 40. mu.L) and stored at-80 ℃.
Respectively amplifying virus RNA containing a target gene region by using specific primers without universal primers, connecting the amplified PCR product to a pGEX-T vector to perform monoclonal construction of plasmids, extracting clone plasmids, performing SpeI enzyme digestion linearization, purifying the linearized plasmids by using a gene purification kit, performing in vitro transcription by using a T7 transcription kit, measuring the RNA concentration by using an ultraviolet spectrophotometer, and calculating the copy number of each virus RNA.
The universal primers were diluted to a working concentration of 10. mu. mol/L and the specific primers were diluted to a working concentration of 1. mu. mol/L. 3 kinds of virus RNA are extracted as templates, and a reaction system is prepared according to a one-step RT-PCR kit: 2.5. mu.L of 10 XTRT-PCR buffer, 2. mu.L of dNTP premix, 1. mu.L of RT-PCR Enzyme Mix, 0.1. mu.L of RNase inhibitor, 1. mu.L of upstream and downstream chimeric primers (1. mu. mol/L), 1. mu.L of upstream and downstream universal primers (10. mu. mol/L), 2. mu.L of template RNA, and 25. mu.L of nuclease-free water. After condition optimization, the reaction conditions are finally determined as follows: reverse transcription is carried out at 45 ℃ for 30min and at 94 ℃ for 15 min; then: 30s at 94 ℃, 30s at 55 ℃, 30s at 72 ℃ and 10 cycles; 30s at 94 ℃, 30s at 65 ℃, 30s at 72 ℃ and 10 cycles; 30s at 94 ℃, 30s at 50 ℃, 30s at 72 ℃ and 20 cycles; 10min at 72 ℃ for 1 cycle. The reaction products were analyzed by GeXP system capillary electrophoresis.
The chimeric primers corresponding to the viruses are respectively mixed in equal amount to prepare multiple mixed primers, the concentration of each primer is 10 mu mol/L, the final concentration in a reaction system is 50nmol/L, other components in the reaction system are identical to single RT-PCR, and 3 virus inactivation sample nucleic acids are taken to verify the specificity of each primer in the multiple RT-PCR detection system.
Gradient dilution of in vitro transcribed viral RNA to 105、104、103、102、101The sensitivity of the multiplex system was measured by taking 1. mu.L of each of the copies/. mu.L as a template.
And adjusting the concentration of each pair of primers according to the sensitivity test result of the multi-primer single template. The 3 viruses in vitro transcription RNA is mixed in equal concentration and diluted to 10 in gradient6、105、104、103、102Copy/. mu.L is used as a simulated mixed sample, and the rest reaction conditions are unchanged, so that the multi-primer multi-template sensitivity analysis is carried out. The experiment is repeated three times on different days, the detection result is recorded, and the coefficient of variation CV of each gene detection is calculated.
Detailed Description
Example 1 primer validation
Analyzing the single RT-PCR product by GeXP system capillary electrophoresis, wherein the amplified fragment size of each target gene is BTV: 306-310 bp, BVDV: 347-352 bp, FMDV: 365-370 bp, and the size of the amplified fragment is consistent with the design.
Example 2 multiplex detection System establishment and Single-template specificity verification results
In the multi-primer detection system, only a specific fragment of a single virus template is amplified in each reaction, and no cross reaction exists, which indicates that the method has strong specificity, and can distinguish viruses according to the sizes of the amplified fragments, and the result is shown in figure 1.
Example 3 Single template sensitivity test results for multiple detection systems
The cloned plasmid in vitro transcription RNA is used as a template, and the detection lower limits of various viruses are respectively as follows: FMDV was 10 copies/. mu.L and BVDV was 100 copies/. mu.L.
Example 4 Multi-template sensitivity results for multiple detection systems
After optimizing the reaction conditions, the multiplex detection system can be at 106、105、104、103、102Copy/. mu.L levels were tested simultaneously for 3 mock mixed templates of viral RNA, and the results are shown in FIG. 2. The experiment was repeated three times on different days at 104When the virus is copied/microliter, the variation coefficient of each virus gene is between 1.2 and 7.6 percent.
Claims (3)
1. A primer combination for simultaneously detecting Foot-and-Mouth Disease (FMD), Bovine Viral Diarrhea (BVD) and Bluetongue Disease (BT), is characterized in that specific chimeric primers and universal primer sequences are shown as SEQ NO: 1 to 8.
2. Use of the primer combination of claim 1 for preparing a diagnostic reagent for Foot and Mouth Disease (FMD), Bovine Viral Diarrhea (BVD), and Bluetongue (BT).
3. A kit for simultaneously detecting Foot-and-Mouth Disease (FMD), Bovine Viral Diarrhea (BVD) and Bluetongue (BT), which comprises the primer combination of claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510784508.XA CN105603120B (en) | 2015-11-17 | 2015-11-17 | GeXP multiple rapid detection primer and detection method for detecting bluetongue virus, bovine viral diarrhea virus and foot-and-mouth disease virus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510784508.XA CN105603120B (en) | 2015-11-17 | 2015-11-17 | GeXP multiple rapid detection primer and detection method for detecting bluetongue virus, bovine viral diarrhea virus and foot-and-mouth disease virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105603120A CN105603120A (en) | 2016-05-25 |
| CN105603120B true CN105603120B (en) | 2021-08-27 |
Family
ID=55983456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510784508.XA Expired - Fee Related CN105603120B (en) | 2015-11-17 | 2015-11-17 | GeXP multiple rapid detection primer and detection method for detecting bluetongue virus, bovine viral diarrhea virus and foot-and-mouth disease virus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105603120B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106191309A (en) * | 2016-07-19 | 2016-12-07 | 广西壮族自治区兽医研究所 | A kind of primer combination simultaneously differentiating 8 kinds of cattle disease substances and GeXP detection method |
| CN105969913A (en) * | 2016-07-19 | 2016-09-28 | 广西壮族自治区兽医研究所 | Primer combination and GeXP detection method for simultaneously identifying 5 bovine viral dermatitis viruses |
| CN108588275A (en) * | 2018-03-23 | 2018-09-28 | 重庆出入境检验检疫局检验检疫技术中心 | The multiple RT-PCR kit and its detection method of BTV-10 types, 20 types, 23 type genotypings |
| CN108342510B (en) * | 2018-03-23 | 2021-08-03 | 重庆出入境检验检疫局检验检疫技术中心 | Multiple RT-PCR kit for BTV-11 type, 17 type, 20 type, 23 type and 24 type genotype typing identification and detection method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1308521A1 (en) * | 2001-10-30 | 2003-05-07 | Hong Kong DNA Chips Limited | A process for detecting foot-and-mouth disease virus and a kit therefor |
| US8354514B2 (en) * | 2007-01-12 | 2013-01-15 | Lawrence Livermore National Security, Llc | Multiplex detection of agricultural pathogens |
| CN103695566A (en) * | 2014-01-14 | 2014-04-02 | 徐超 | Multiplex PCR (polymerase chain reaction) primer, probe and gene chip for detecting bluetongue virus, foot and mouth disease virus and bovine viral diarrhea virus |
| CN105002301A (en) * | 2015-07-31 | 2015-10-28 | 中华人民共和国北京出入境检验检疫局 | Multiple-connection probe amplification detection kit, primer and probe for simultaneously detecting five cow disease viruses |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007020990A1 (en) * | 2005-08-12 | 2007-02-22 | Nihon University | Gene involved in occurrence/recurrence of hcv-positive hepatocellular carcinoma |
| US20100211327A1 (en) * | 2009-02-03 | 2010-08-19 | Prosetta Bioconformatics, Inc. | Methods and Systems for Viral Diagnosis |
-
2015
- 2015-11-17 CN CN201510784508.XA patent/CN105603120B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1308521A1 (en) * | 2001-10-30 | 2003-05-07 | Hong Kong DNA Chips Limited | A process for detecting foot-and-mouth disease virus and a kit therefor |
| US8354514B2 (en) * | 2007-01-12 | 2013-01-15 | Lawrence Livermore National Security, Llc | Multiplex detection of agricultural pathogens |
| CN103695566A (en) * | 2014-01-14 | 2014-04-02 | 徐超 | Multiplex PCR (polymerase chain reaction) primer, probe and gene chip for detecting bluetongue virus, foot and mouth disease virus and bovine viral diarrhea virus |
| CN105002301A (en) * | 2015-07-31 | 2015-10-28 | 中华人民共和国北京出入境检验检疫局 | Multiple-connection probe amplification detection kit, primer and probe for simultaneously detecting five cow disease viruses |
Non-Patent Citations (7)
| Title |
|---|
| "2013 年内蒙古地区蓝舌病流行情况调查";张胜男等;《中国预防兽医学报》;20141031;第36卷(第10期);第759-762页 * |
| "Primary diagnosis of foot-and-mouth disease by reverse transcription polymerase chain reaction";Scott M. Reid等;《Journal of Virological Methods》;20000930;第89卷(第1-2期);第167-176页 * |
| "Serological and molecular evidence of bluetongue in sheep and goats in Uttar Pradesh, India";Molalegne Bitew等;《African Journal of Biotechnology》;20130508;第12卷(第19期);第2699-2705页 * |
| "***病毒实时RT-PCR检测方法的建立";李永东等;《中国***共患病学报》;20060330;第22卷(第3期);第212-215,258页 * |
| "同时检测***病毒和牛肠道病毒双重RT-PCR方法的建立";吴丹等;《中国预防兽医学报》;20121231;第34卷(第12期);第976-979页 * |
| "皮毛中5种病毒基因芯片检测方法的研究";徐超等;《动物医学进展》;20130420;第34卷(第4期);第27-32页 * |
| "进口奶牛病毒性腹泻病毒快速检测鉴定";赵秀玲等;《中国兽医学报》;20071130;第27卷(第6期);第807-809页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105603120A (en) | 2016-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106947838B (en) | African swine fever virus non-structural gene real-time fluorescence LAMP (loop-mediated isothermal amplification) detection primer group, kit and detection method | |
| CN106435024B (en) | Fluorescent quantitative PCR primer, probe, kit and detection method for detecting avian influenza virus subtype | |
| CN105420412B (en) | Pig Delta coronavirus and Porcine epidemic diarrhea virus multiple RT-PCR detection primer and detection method | |
| CN105603120B (en) | GeXP multiple rapid detection primer and detection method for detecting bluetongue virus, bovine viral diarrhea virus and foot-and-mouth disease virus | |
| Fischer et al. | Detection and differentiation of field and vaccine strains of canine distemper virus using reverse transcription followed by nested real time PCR (RT-nqPCR) and RFLP analysis | |
| CN106048094B (en) | Dual real-time fluorescent quantitative PCR (polymerase chain reaction) detection kit, primers and probe for porcine pseudorabies wild strains and gene-deleted strains | |
| CN103981286B (en) | Differentiate GeXP rapid detection kit and the primer sets thereof of 8 kinds of virus diseases of pigs | |
| CN103757139A (en) | Canine distemper virus and canine parvovirus duplex TaqMan-MGB fluorescent quantitative PCR (polymerase chain reaction) detection kit and detection method thereof | |
| CN105567868B (en) | GeXP multiple rapid detection primers and detection method for detecting akabane virus, bovine viral diarrhea virus and bluetongue virus | |
| CN105586438B (en) | GeXP multiple rapid detection primers and detection method for detecting akabane virus, foot-and-mouth disease virus and bluetongue virus | |
| CN105400910B (en) | Pig Delta coronavirus and transmissible gastro-enteritis virus multiple RT-PCR detection primer and detection method | |
| CN104263857B (en) | A kind of nano PCR kit of quick detection mink enteritis virus and its application | |
| CN106222298B (en) | LAMP detection kit, detection method and application of RNA virus | |
| CN111518955A (en) | HRM primer pair, kit and method for rapidly identifying feline enterocoronavirus and feline infectious peritonitis virus | |
| CN110878381A (en) | Primer composition, kit and method for detecting mycoplasma bovis and infectious bovine rhinotracheitis virus | |
| CN105002284A (en) | Haemophilus paragallinarum fluorogenic quantitative PCR detection method | |
| CN105586437B (en) | Establishment of detection method for GeXP virus carried by four entry cows | |
| CN105567869B (en) | GeXP multiple primers and method for detecting akabane virus, bovine viral diarrhea virus and foot-and-mouth disease virus | |
| CN111676316A (en) | Primer, probe and detection method for rapidly distinguishing African swine fever virus gene type II from other genotypes | |
| CN103215389B (en) | Porcine reproductive and respiratory syndrome and porcine Japanese B encephalitis dual one-step RT-PCR (Reverse Transcription-Polymerase Chain Reaction) diagnosis kit | |
| CN102586485B (en) | Real time-loop-mediated isothermal amplification (RT-LAMP) detection primers for performing differential diagnosis on canine distemper virus wild strains and vaccine strains and application of primers | |
| CN104313179A (en) | Isothermal amplification detection kit and detection method for Zaire type Ebola virus | |
| CN104894112B (en) | A kind of Japanese B encephalitis virus real-time fluorescence isothermal amplification detection kit and its primer and probe | |
| CN104862418A (en) | Specific primers for detecting European-type porcine reproductive and respiratory syndrome viruses and corresponding detection kit | |
| CN106191314B (en) | LAMP detection kit, detection method and application of DNA virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 300457 No.51, 2nd Street, Tianjin Development Zone, Dongli District, Tianjin Applicant after: Tianjin Customs Animal, Plant and Food Inspection Center Address before: No.158, Jingmen Avenue, Tianjin Port Free Trade Zone, Tianjin 300461 Applicant before: ANIMAL & PLANT AND FOOD INSPECTION CENTER OF TIANJIN ENTRY-EXIT INSPECTION AND QUARANTINE BUREAU |
|
| CB02 | Change of applicant information | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210827 |